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Amajor challenge in nuclear organization is the packaging of DNA into dynamic chromatin structures that can
respond to changes in the transcriptional requirements of the cell. Posttranslational protein modifications, of
histones and other chromatin-associated factors, are essential regulators of chromatin dynamics. In this
Review, we summarize studies demonstrating that posttranslational modification of proteins by small ubiq-
uitin-related modifiers (SUMOs) regulates chromatin structure and function at multiple levels and through
a variety of mechanisms to influence gene expression and maintain genome integrity.Introduction
The discovery of the nucleosome, the discovery of the iconic
‘‘beads on a string,’’ and finally the realization that there are
higher-order chromatin-packing structures have made it clear
thatDNA is intricately organized. Since this time, significant prog-
ress has been made in identifying the proteins responsible for
higher-order DNA packaging and in understanding how regula-
tion of these proteins affects chromatin structure. A major theme
that has emerged is the important role of posttranslational protein
modifications in modulating the functional accessibility of DNA.
Of particular interest, recent global proteomic and genetic
studies have linked modification by the small ubiquitin-related
modifier (SUMO) to many processes involving chromatin,
including transcriptional activation and repression, DNA replica-
tion and repair, andchromosomesegregation (Golebiowski et al.,
2009; Makhnevych et al., 2009). Here, we review the current
knowledge of how SUMO modification (sumoylation) of chro-
matin-associated proteins regulates chromatin structure and
function and thereby controls these essential cellular processes.
After introducing the sumoylation pathway and general
connections between SUMO and chromatin, we will discuss
the complex role of sumoylation in both euchromatin and hetero-
chromatin environments. First, the multiple mechanisms by
which sumoylation modulates gene expression through effects
on DNA methylation, histones, and transcriptional regulators
will be reviewed. Subsequently, the functional role of sumoyla-
tion in repetitive DNA structures, including ribosomal DNA
(rDNA), telomeres, and centromeres will be discussed. We will
highlight the unique functions of sumoylation within each of
these domains, as well as its common role as a protector of
genomic integrity.
Several emerging themes will be reiterated throughout the
Review. First, sumoylation often functions as a signal to facilitate
protein-protein interactions on chromatin. These interactions
may be simple heterodimeric associations, but they can also
involve assembly of very large multiprotein complexes. Second,
sumoylation also specifies multiple other fates, including effects
on enzyme activity and changes in protein subcellular localiza-
tion. And lastly, although in many cases sumoylation is linked
to heterochromatin and gene inactivation, a growing number ofstudies indicate that sumoylation also plays important roles in
enhancing chromatin accessibility and gene activation. Thus,
the effects of sumoylation are dichotomous and often context
dependent.
SUMO Modification and Function
Mechanistically, sumoylation occurs through an enzyme
cascade very similar to ubiquitylation (Figure 1A). The SUMO
paralogs are synthesized as precursor proteins that are cleaved
by a family of SUMO isopeptidases referred to as SENPs
(Mukhopadhyay and Dasso, 2007). Mature SUMO is subse-
quently activated by a heterodimeric E1 activating enzyme
(Aos1/Uba2), transferred to an E2 conjugating enzyme (Ubc9),
and finally transferred to lysine residues in target proteins.
This last step may be facilitated by the action of E3 ligases,
which, in addition to enhancing rates of sumoylation, are also
believed to contribute to specificity (Gareau and Lima, 2010;
Johnson, 2004). Substrate specificity in the sumoylation path-
way, however, still remains poorly understood, because only
a single E2 enzyme and relatively few E3 ligases have been iden-
tified. Sumoylation is, however, highly dynamic and can be
reversedby the action of desumoylating enzymes. In vertebrates,
these isopeptidases include a family of six SENPs defined by a
conserved cysteine protease domain, distinct subcellular locali-
zations, and nonredundant functions (Mukhopadhyay and
Dasso, 2007). In addition, several unique desumoylating en-
zymes have more recently been identified, including the metallo-
protease Wss1, the PPPDE-domain-containing proteins DeSI-1
and DeSI-2, and the ubiquitin-specific protease-like protein 1
(USPL1) (Mullen et al., 2010; Schulz et al., 2012; Shin et al.,
2012). Sumoylation of individual proteins is likely to be regulated
by a fine-tuned balance between conjugation and deconjugation
(Gareau and Lima, 2010). Consistent with this, and as outlined
below, both SUMO-conjugating and SUMO-deconjugating
enzymes are important effectors of chromatin structure.
Sumoylation of proteins can affect protein stability or enzy-
matic activity, alter localization, or mediate novel protein-protein
interactions with other proteins containing SUMO-interacting
motifs (SIMs) (Figure 1B) (Geiss-Friedlander and Melchior, 2007;
Kerscher, 2007). In many instances, sumoylation may play a roleDevelopmental Cell 24, January 14, 2013 ª2013 Elsevier Inc. 1
Figure 1. The SUMO Pathway and Molecular Consequences of Sumoylation
(A) SUMO is synthesized as a precursor, processed to a mature form by SUMO-specific isopeptidases and covalently conjugated to protein substrates via an E1,
E2, and E3 enzyme cascade. Sumoylated protein substrates are demodified by SUMO-specific isopeptidases.
(B) The molecular consequences of sumoylation (S) include protein targeting, alteration of protein or enzyme function, effects on protein stability, and effects on
protein-protein interactions. Sumoylation can promote or antagonize protein stability by either blocking ubiquitylation of lysine residues or by promoting ubiq-
uitylation (Ub) upon recognition by SUMO-targeted ubiquitin ligases (STUbL). Effects on protein-protein interactions may be modulated at multiple levels,
including polymeric chain formation and intersection with other posttranslational modifications such as phosphorylation (P).
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between proteins that are covalently modified by SUMO and/or
contain SIMs, as exemplified by promyelocytic leukemia (PML)
nuclear bodies. In these subnuclear structures, SUMO acts as
a scaffold to mediate interactions between the PML protein and
other associated factors (Matunis et al., 2006; Shen et al., 2006).
Although multiple effects of sumoylation on proteins have been
discovered, the ability of SUMO to promote the assembly of
multiprotein complexes is an especially prominent theme.
The diverse effects of sumoylation may be explained in part
through the generation of functionally distinct signals. Although
invertebrates express only a single SUMO, vertebrates express
four paralogs (SUMO-1, SUMO-2, SUMO-3, and SUMO-4),
each with the potential to act as unique signals by interacting
with distinct downstream factors (Kerscher, 2007). SUMO-2
and SUMO-3 share97% identity with each other and probably
represent redundant signals and are thus referred to as SUMO-
2/3. However, they share only 50% identity with SUMO-1
(Gareau and Lima, 2010). SUMO-4 shares 86% identity with
SUMO-2/3, but questions exist about its ability to be conjugated
to other proteins (Owerbach et al., 2005; Wei et al., 2008). The
ability of SUMOs to form polymeric chains provides an additional
opportunity for signal diversification (Figure 1B) (Kerscher, 2007).
Currently, the best-studied functional role for polymeric SUMO
chains involves their recognition by SUMO-targeted ubiquitin
E3 ligases containing tandem SIMs (Perry et al., 2008). Other
functional distinctions between paralogs and polymers
remain to be fully understood. Finally, the diverse effects of
sumoylation can also be explained through intersections with
other posttranslational modification pathways (Figure 1B). For
example, both phosphorylation and acetylation affect interac-
tions between SUMO and downstream SUMO-binding proteins
(Chang et al., 2011; Ullmann et al., 2012).
General Connections among Sumoylation, Chromatin,
and Transcription
Associations between sumoylation and chromatin structure
have been well documented through numerous immunofluores-2 Developmental Cell 24, January 14, 2013 ª2013 Elsevier Inc.cence microscopy studies. All three SUMO paralogs, for
example, are detected in the heterochromatin XY bodies of rat
pachytene spermatocytes (La Salle et al., 2008; Rogers et al.,
2004; Vigodner, 2009; Vigodner et al., 2006), and SUMO-1 is
associated with long stretches of constitutive heterochromatin
in human spermatocytes (Metzler-Guillemain et al., 2008). In
mitotic cells, SUMO-2/3 has been observed at the inner centro-
mere of chromosomes and also along the length of chromosome
arms as cells progress from metaphase through telophase
(Ayaydin and Dasso, 2004; Azuma et al., 2005; Zhang et al.,
2008). Associations between SUMO and mitotic chromosomes
are also detected in Saccharomyces cerevisiae (Biggins et al.,
2001) and in Drosophila melanogaster using polytene chromo-
some spreads (Lehembre et al., 2000), suggesting that sumoyla-
tion of chromatin-associated proteins has a conserved and
fundamentally important function.
Associations between SUMO and chromatin are further sup-
ported by biochemical studies, including chromatin immunopre-
cipitation experiments (ChIP). In Schizosaccharomyces pombe,
for example, ChIP experiments revealed that the SUMO E2
conjugating enzyme Ubc9 is chromatin bound and specifically
enriched in regions of heterochromatin (Shin et al., 2005). Simi-
larly, fractionation of Xenopus laevis egg extracts demonstrated
interactions between PIAS E3 ligases and chromatin (Azuma
et al., 2005). Surprisingly, a comprehensive genome-wide ChIP
analysis to detect the precise association of SUMO or SUMO-
modified proteins with chromatin has not yet been reported.
However, more targeted studies link SUMO or SUMO pathway
enzymes to distinct chromatin domains, including pericentric
heterochromatin, PcG bodies, the nucleolus, telomeres, and
centromeres, as reviewed in detail below.
Studies related to the involvement of sumoylation in control-
ling transcription regulation provide the strongest evidence
for functional links between SUMO and chromatin. Genetic
approaches have revealed a general causal relationship
between sumoylation and gene repression. Inducing hypersu-
moylation by targeting SUMO and/or Ubc9 to specific gene
promoters primarily induces gene repression (Chupreta et al.,
Figure 2. Sumoylation Functions as an Activator and a Repressor of Gene Expression
(A) Sumoylation represses gene expression by promoting DNA methylation (yellow dots) through DNMT1 activation.
(B) Sumoylation represses gene expression by facilitating assembly of repressive complexes onmethylated DNA and at promoters. Sumoylation also inhibits the
activities of transcription factors (TFs) and affects HDAC recruitment and function.
(C) Sumoylation promotes the assembly of repressive PcG bodies.
(D) Sumoylation promotes DNA demethylation and gene activation through mechanisms involving the SUMO-targeted ubiquitin E3 ligase activity of RNF4.
(E) Sumoylation facilitates the assembly of complexes on chromatin that promote transcription.
(F) Sumoylation positively influences RNA polymerase II (RNA Pol II) recruitment to constitutively active gene promoters.
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sumoylation by overexpressing SUMO isopeptidases or by
depleting cells of Ubc9 or SUMO enhances ectopic gene
expression (Ouyang et al., 2009; Poulin et al., 2005; Spektor
et al., 2011). These effects are mediated at multiple levels,
including direct effects on transcription factor activities (Gill,
2005). Transcription factors and coregulators make up one
of the most abundant classes of SUMO-modified proteins.
Although clearly able to mediate transcriptional repression,
sumoylation is not simply a negative regulator of transcription.
The dichotomous role of SUMO in gene regulation is demon-
strated by the observations that sumoylation of certain transcrip-
tion factors, including Ikaros, enhances their transcriptional
activity (Figure 2E) (Go´mez-del Arco et al., 2005).
Studies in yeast also provide a striking example of the
complexities of sumoylation as both an activator and repressor
of transcription. ChIP analysis in S. cerevisiae reveals the pres-
ence of sumoylated proteins at the promoters of constitutively
active genes and the recruitment of Ubc9 and SUMO to
promoters of inducible genes in response to activation (Rosonina
et al., 2010). Surprisingly, sumoylation is required not only for
optimal transcriptional activation of constitutive genes, but also
for repression and timely inactivation of inducible genes. At
constitutively active genes, sumoylation enhances transcription
by promoting RNA polymerase II recruitment (Figure 2F).
However, at inducible promoters, sumoylation functions down-
stream of transcription initiation. Specifically, sumoylation of
the transcription factor Gcn4 promotes its removal from pro-
moters and its degradation, thereby limiting transcription reinitia-
tion (Rosonina et al., 2010, 2012).Another elegant example of the subtle and complex effects of
sumoylation on transcription is illustrated by phenotypes in mice
expressing a mutant form of the SF-1 transcription factor that
cannot be sumoylated. Although studies in cultured cells indi-
cate that sumoylation negatively regulates SF-1 transcriptional
activity, mice expressing nonsumoylatable SF-1 fail to pheno-
copy a constitutively active SF-1 (Lee et al., 2005, 2011). Thus,
sumoylation does not function as a simple on-off switch,
but rather enhances the functional diversity of SF-1, adding
a layer of regulation for fine-tuning gene expression during
development.
The utility of sumoylation as a mechanism to fine-tune tran-
scription can be explained in part on its broad effects on chro-
matin modifications and structure. This is illustrated by studies
of a well-characterized SUMO-1 modified transcription factor,
Sp3. In cells expressing specific mutant isoforms of Sp3 that
cannot be sumoylated, transcription activation and chromatin
modifications at Sp3-targeted promoters are dramatically
different from those observed at the same promoters in cells ex-
pressing wild-type Sp3. For instance, levels of both DNA and
histonemethylation are reduced at promoters in cells expressing
mutant Sp3 and, concomitantly, levels of histone methyltrans-
ferases, heterochromatin protein 1 (HP1), and two ATP-depen-
dent chromatin remodelers are also reduced (Ross et al., 2002;
Stielow et al., 2008a, 2008b, 2010). These findings provide a
relatively simple view of how sumoylation of just one transcrip-
tion factor exerts multiple effects—some direct and others indi-
rect—to alter chromatin structure. However, even in the case of
Sp3, the situation is not so simple, as evidenced through addi-
tional studies demonstrating that the effects of sumoylation areDevelopmental Cell 24, January 14, 2013 ª2013 Elsevier Inc. 3
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promoters (Ellis et al., 2006; Sapetschnig et al., 2004). An
emerging view is that sumoylation sits at the intersection of
multiple pathways, affecting the activities of not only transcrip-
tion factors, but also other chromatin-associated proteins
and chromatin-modifying enzymes. Thus, effects of sumoylation
on gene expression and chromatin structure represent collective
effects on multiple, context-dependent levels (Figure 2). How
sumoylation affects gene expression at the level of chromatin
structure and accessibility, and within the context of distinct
genomic subdomains, is the focus of the following sections.
DNA Methylation
DNA methylation of CpG dinucleotides restricts DNA accessi-
bility by two mechanisms. Methylation blocks the binding of
sequence-specific DNA binding proteins and/or recruits chro-
matin-modifying complexes that promote a restrictive chromatin
structure (Bird, 2002). Multiple lines of evidence indicate that su-
moylation plays important roles in regulating CpG methylation
and demethylation, as well as the assembly and functions of
downstream complexes recruited to methylated DNA.
First, sumoylation of DNA methyltransferases (Dnmts) may
alter their enzymatic activity (Figure 2A). This has been demon-
strated most clearly for the maintenance methyltransferase,
Dnmt1, whose SUMO-1 modification increases its activity
toward S phase hemimethylated DNA substrates in vitro (Lee
and Muller, 2009). In addition, the de novo DNA methyltrans-
ferases Dnmt3a and Dnmt3b are both sumoylated in vivo,
although the functional consequences of their modifications
remain to be fully elucidated (Kang et al., 2001; Li et al., 2007;
Ling et al., 2004). Strikingly, nearly all of Dnmt3a is sumoylated
in cells overexpressing SUMO-1, an effect that correlates
with a disruption of Dnmt3a’s interactions with histone deacety-
lases 1 and 2 (HDAC1 and HDAC2) and a loss of Dnmt3a-
mediated repression (Ling et al., 2004). Further studies are
needed to determine whether these effects are strictly related
to Dnmt3a sumoylation.
In addition to regulating DNA methylation, sumoylation also
promotes DNA demethylation through mechanisms mediated
by RNF4, a ubiquitin E3 ligase that specifically recognizes and
ubiquitylates sumoylated proteins (Figure 2D) (Hu et al., 2010;
Perry et al., 2008). RNF4 deficiency is embryonic lethal in mice.
Rnf4/ mouse embryonic fibroblasts, however, are viable but
exhibit hypermethylation of genomic DNA. Conversely, overex-
pression of wild-type RNF4, but not SUMO-binding or ubiquitin
ligase mutants, results in global DNA demethylation (Hu et al.,
2010). Thus, SUMO and ubiquitylation are required for RNF4-
mediated DNA demethylation, although the precisemechanisms
of action remain unclear. Intriguingly, one favoredmodel for DNA
demethylation is based on deamination of methylcytosines to
create T:G mismatches that are repaired by thymidine DNA
glycosylase (TDG) and base-excision repair (BER) (Wu and
Zhang, 2010). TDG is known to interact with RNF4 (Hu et al.,
2010), and sumoylation has been proposed to play an important
role in regulating TDG by enhancing its enzymatic turnover (Baba
et al., 2005; Hardeland et al., 2002). Thus, ubiquitylation of
sumoylated TDG or other interacting proteins could produce
a signal required for DNA demethylation and possibly BER in
general.4 Developmental Cell 24, January 14, 2013 ª2013 Elsevier Inc.Sumoylation also functions downstream of DNA methylation,
affecting the assembly of methyl-CpG binding domain (MBD)
proteins and other factors with methylated DNA (Figure 2B)
(Bogdanovic and Veenstra, 2009). SUMO-1 and SUMO-2/3
both localize to heterochromatin domains enriched in MBD1,
as well as heterochromatin proteins HP1 and MCAF1 (Uchimura
et al., 2006). Formation of these heterochromatin domains is
SUMO dependent, because knockdown of either SUMO-1 or
SUMO-2/3 disrupts the colocalization of HP1 and MCAF1 with
MBD1-containing foci (Uchimura et al., 2006). Intriguingly,
MBD1 and HP1 are both sumoylated, whereas MCAF1 binds
all three SUMO paralogs (Lyst et al., 2006; Maison et al., 2011;
Uchimura et al., 2006). Thus, it is tempting to speculate that
MBD1-containing heterochromatin domains are organized
around covalent and noncovalent SUMO interactions in a fashion
similar to PML nuclear bodies (Matunis et al., 2006). In contrast
with these repressive functions, however, sumoylation of
MBD1 also interferes with its interactions with the histone meth-
yltransferase SETDB1, and might thereby limit gene inactivation
(Lyst et al., 2006). Therefore, sumoylation underlies multiple
mechanisms for fine-tuning the functional properties of methyl-
ated DNA through effects both positive and negative, again
demonstrating the dichotomous effects of SUMO on gene
expression.
Histones and HDACs
Posttranslational modification of histones also represents
a central mechanism for controlling chromatin structure and
gene expression, and not surprisingly, histones are sumoylated.
All four histones, as well as the H2A.Z variant, are sumoylated in
S. cerevisiae (Kalocsay et al., 2009; Nathan et al., 2006), whereas
only H4 has been shown to bemodified inmammalian cells (Shiio
and Eisenman, 2003). The functional significance of histone
sumoylation is surprisingly not well understood. ChIP experi-
ments involving exogenously expressed SUMO-histone fusion
proteins in yeast reveal enrichment at subtelomeric regions, an
area of the genome where SUMO is generally thought to antag-
onize transcriptional repression (Nathan et al., 2006; Xhemalce
et al., 2004; Zhao and Blobel, 2005). In contrast, expression
of SUMO-histone fusion proteins represses transcriptional
reporters in both mammalian cells and in yeast at least in part
through recruitment of HDACs and HP1 (Nathan et al., 2006;
Shiio and Eisenman, 2003). Such findings suggest that histone
sumoylation functions as a signal to recruit proteins to chromatin
(Figure 2B). Consistent with this general concept, recruitment of
the transcription corepressor complex, LSD1/CoREST1/HDAC
to chromatin is dependent on an SIM in CoREST1 (Ouyang
et al., 2009). Whether CoREST1 recognizes sumoylated histones
and/or other sumoylated factors, however, remains to be
determined.
In addition to histones, multiple studies have identified HDACs
as another important effector of SUMO-mediated transcriptional
repression. Most simply, HDACs themselves are sumoylated
(Figure 2B). Sumoylation of HDAC1 and HDAC4 is required for
the full transcriptional repression activities at defined promoters
(Cheng et al., 2004; David et al., 2002; Kirsh et al., 2002).Whether
sumoylation directly affects HDAC activity or acts as a signal for
the recruitment of other chromatin repressors, however, is a
question that remains to be fully addressed. In addition to being
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response to sumoylation of other factors, including transcription
factors and cofactors such as Elk-1 and p300 (Garcia-Domi-
nguez and Reyes, 2009; Girdwood et al., 2003; Yang and
Sharrocks, 2004). These findings suggest that HDAC recruitment
may be mediated through noncovalent interactions with SUMO,
a suggestion that has been confirmed at least for HDAC1, which
contains a functionally important SIM (Ahn et al., 2009). A third
level of association between HDACs and sumoylation has
been made based on the observations that HDACs 4, 5, and 7
appear to function as SUMO E3 ligases for certain substrates
(Gao et al., 2008; Yang et al., 2011; Zhao et al., 2005). These
findings are based largely on effects of HDAC overexpression,
where an alternative mechanism for enhanced sumoylation
might involve substrate binding and protection from isopepti-
dases. In either case, HDAC interaction would provide a feed-
forward mechanism for enhancing sumoylation-mediated
histone deacetylation and repression.
Polycomb Group Bodies
Polycomb group (PcG) bodies are subnuclear structures that
function as small hubs of transcriptional repression. To facilitate
repression, PcG bodies cluster distant DNA promoter elements
and recruit chromatin-remodeling complexes called polycomb
repressive complexes (Bantignies and Cavalli, 2011). Given
its involvement in repression and organizing large protein
complexes, it is not surprising that SUMO localizes to PcG
bodies (Figure 2C) (Kagey et al., 2003). In addition to SUMO,
Ubc9, the SUMO isopeptidase SENP2, and the SUMO E3 ligase
Cbx4/Pc2 all localize to PcG bodies (Kagey et al., 2003, 2005;
Kang et al., 2010). Because Pc2 stimulates the sumoylation of
many repressive proteins, including Dnmt3a, CTCF, and compo-
nents of the polycomb repressive complex 2, it is attractive to
speculate that sumoylation regulates the dynamic recruitment
and assembly of these proteins within PcG bodies in a fashion
similar to PML nuclear bodies (Li et al., 2007; MacPherson
et al., 2009; Matunis et al., 2006; Riising et al., 2008).
Consistent with essential functions in PcG body-mediated
repression, two independent studies have demonstrated links
between sumoylation and expression of PcG-body regulated
genes. In C. elegans, depletion of SUMO, E1, or E2 conjugating
enzymes results in ectopic expression of Hox genes normally
controlled by PcG body recruitment (Zhang et al., 2004). The
appropriate repression of Hox genes is dependent at least in
part on sumoylation of the PcG protein SOP-2, which is required
for the association of SOP-2 with PcG bodies (Zhang et al.,
2004). SUMO-dependent assembly of PcG bodies is also
conserved in mammalian cells and is also critical for normal
gene expression during embryonic development. In particular,
assembly of the polycomb repressive complex 1 (PRC1) at
the promoters of genes important for normal heart development
is misregulated in mice deficient in the SENP2 isopeptidase
(Kang et al., 2010). This misregulation is due in part to hypersu-
moylation of the Cbx4/Pc2 SUMO E3 ligase and enhanced
assembly of PRC1 complexes on the promoters of PcG
target genes. These findings illustrate the important balance
between SUMO-conjugating enzymes and isopeptidases, which
is a common theme in ubiquitylation (Sowa et al., 2009). Further
studies are required to understand how the activities of Cbx/Pc2and SENP2 are normally regulated to affect proper PcG body
function.
Finally, in another example of the dichotomous effects of
sumoylation, assembly of the PcG protein Sex Comb on Midleg
(Scm) into repressor complexes in D. melanogaster appears to
be negatively regulated by its SUMO modification (Smith et al.,
2011). Whether sumoylation has universally opposing effects
on PcG body formation in D. melanogaster compared to other
organisms remains to be determined. An alternative and more
appealing scenario is that sumoylation both positively and nega-
tively affects PcG body assembly, with the ultimate effects on
individual protein recruitment and gene expression being influ-
enced by multiple, context-dependent factors and interactions.
Chromatin Insulators
Sumoylation also influences gene expression by affecting the
activities of chromatin insulator complexes. This function was
first revealed by studies in D. melanogaster, demonstrating
that loss of the PIAS E3 ligase homolog results in ablation of
heterochromatin-euchromatin barriers and normal polytene
chromosome banding patterns (Hari et al., 2001). Consistent
with a role in regulating insulator functions, SUMO was subse-
quently localized to insulator bodies in D. melanogaster, and
two of the major protein components, Mod(mdg4)2.2/67.2 and
CP190, were found to be sumoylated (Capelson and Corces,
2006; Golovnin et al., 2012). However, the function of SUMO in
organizing and regulating the function of insulators is still
unclear. Enhancing sumoylation by Ubc9 overexpression leads
to dispersal of insulator bodies, suggesting that sumoylation
may negatively affect local and/or long-range interactions
between insulator complexes (Capelson and Corces, 2006). In
contrast, SUMO depletion or expression of a Mod(Mdg4)2.2/
67.2 mutant that cannot be sumoylated inhibits insulator body
formation, arguing for a positive role in insulator assembly
(Golovnin et al., 2012). Such opposing findings indicate that insu-
lator assembly and/or maintenance may rely on a finely tuned
balance of sumoylation and desumoylation, as required for the
association or HP1a with pericentric DNA (Maison et al., 2012).
Further analysis is needed to understand the function of SUMO
in insulator activity in Drosophila, and particularly in other
species. CTCF, a well-characterized vertebrate insulator protein,
is sumoylated in human cells, but how sumoylation affects its
insulating activities remains unknown (MacPherson et al., 2009).
The Nucleolus
The nucleolus is a specialized subnuclear domain for ribosomal
RNA (rRNA) gene expression and preribosomal particle assem-
bly (Boisvert et al., 2007). Studies in both vertebrates and yeast
indicate that sumoylation plays important roles in the nucleolus,
including regulation of rRNA processing and preribosomal
particle assembly (Castle et al., 2012; Finkbeiner et al., 2011;
Panse et al., 2006; Yun et al., 2008). Consistent with this,
SUMO-1 and SUMO-2/3 are detected within the nucleolus in
vertebrate cells (Ayaydin and Dasso, 2004; Takahashi et al.,
2008), as are the isopeptidases SENP3 and SENP5 (Gong and
Yeh, 2006). Sumoylation also appears to have important effects
on nucleolar rDNA structure and function. Thus, hyposumoyla-
tion due to defects in the SUMO E3 ligase Mms21, a component
of the Smc5/6 complex, lead to abnormal nucleolar morphologyDevelopmental Cell 24, January 14, 2013 ª2013 Elsevier Inc. 5
Figure 3. Sumoylation Maintains Genome Integrity at Repetitive DNA Domains
(A) Sumoylation limits telomere elongation by regulating interactions between Cdc13 and Stn1.
(B) Sumoylation of unknown proteins affects subtelomeric chromatin structure.
(C) Sumoylation promotes the assembly of ALT PML nuclear bodies (APBs) essential for telomere maintenance in telomerase-deficient cells.
(D) Sumoylation of Rad52 promotes the movement of DNA double-strand breaks from intranucleolar domains to the nucleolar periphery for optimal repair.
(E) Sumoylation of HP1a regulates its association with a-satellite RNA and recruitment to centromeres.
(F) Sumoylation functions to resolve DNA replication and repair intermediates within repetitive DNA domains and to promote decatenation.
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activation of silenced rDNA occurs in S. cerevisiae strains defi-
cient in the Slx5/Slx8 SUMO-targeted ubiquitin E3 ligase (Darst
et al., 2008). How sumoylation affects rDNA chromatin structure
and silencing remains to be fully characterized. However, recent
proteomic identification of the SUMO substrates within the
nucleolus should enhance these efforts (Matafora et al., 2009;
Westman et al., 2010).
Because of the repetitive nature of rDNA genes, specialized
SUMO-dependent DNA repair mechanisms exist to maintain
stability of nucleolar rDNA loci (Figure 3E). DNA double-strand
breaks within rDNA loci are repaired at extranucleolar sites in
a manner dependent on the Smc5/6 complex and sumoylation
of Rad52. Specifically, yeast strains expressing Smc5/6 mutants
or a Rad52 mutant that cannot be sumoylated form DNA repair
foci within the nucleolus itself, and these strains exhibit hyperre-
combination within the rDNA locus (Altmannova et al., 2010;
Torres-Rosell et al., 2007). Whether Mms21-mediated sumoyla-
tion regulates DNA repair in other repetitive sequences by
a similar mechanism remains to be determined, but the role of
SUMO in general repetitive DNA maintenance is reviewed in
detail below.
Telomeres
Telomeres are composed of DNA repeats coated by resident
telomere-binding protein complexes, called shelterin com-
plexes, that protect them from degradation and inappropriate
recognition by DNA repair enzymes (Blasco, 2007). Because
telomere shortening jeopardizes genome integrity, maintenance
of telomere length is a tightly controlled process. Telomeremain-
tenance is controlled through multiple mechanisms, including
recruitment of telomerase (the enzyme that catalyzes the addi-
tion of telomere DNA repeats), modulation of the heterochro-6 Developmental Cell 24, January 14, 2013 ª2013 Elsevier Inc.matin environment of the subtelomeric regions, and modulation
of the alternate lengthening of telomeres (ALT) pathway (Blasco,
2007). In strains of S. cerevisiae and S. pombe defective in
SUMO, Ubc9, or SUMO E3 ligases, telomeres are abnormally
elongated, demonstrating a role for sumoylation in affecting
one or more of these mechanisms (Chen et al., 2007; Hang
et al., 2011; Tanaka et al., 1999; Xhemalce et al., 2004, 2007;
Zhao and Blobel, 2005).
The telomere elongation observed in yeast mutants defective
in sumoylation is telomerase dependent, suggesting that sumoy-
lation normally limits the accessibility of telomeres to telomerase
(Figure 3A) (Xhemalce et al., 2007). To date, there is no demon-
stration that telomerase itself is regulated through sumoylation.
Studies have shown that sumoylation affects the activity of
Cdc13, a single-stranded telomere binding protein and regulator
of telomerase recruitment, by promoting Cdc13 association with
the telomerase inhibitor, Stn1. Consequently, yeast strains
expressing a Cdc13 mutant that cannot be sumoylated have
lengthened telomeres, whereas shortened telomeres are
observed in strains expressing a Cdc13-SUMO fusion (Hang
et al., 2011). Furthermore, multiple components of the shelterin
complex, which is known to limit telomerase recruitment to telo-
meres (de Lange, 2005), are sumoylated (Ferreira et al., 2011;
Hang et al., 2011; Lu et al., 2010; Pebernard et al., 2008; Potts
and Yu, 2007). Sumoylation of one or more of these factors is
likely to contribute to the full inhibitory effect of SUMO on telo-
mere lengthening. However, the underlying molecular mecha-
nisms remain unknown.
Sumoylation may also regulate telomere length by modulating
the heterochromatin environment of the subtelomere (Figure 3B).
Mutations in yeast that disrupt telomeric heterochromatin
structure and silencing also cause shortened telomeres, indi-
cating that heterochromatin proteins positively regulate telomere
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telomere length, this model would predict that sumoylation
antagonizes silencing in the subtelomere. Remarkably, the
data confirm this model despite the more general association
of SUMO with enhanced repression. Reducing levels of sumoy-
lation in yeast leads to increased telomeric silencing (Xhemalce
et al., 2004; Zhao and Blobel, 2005), while increasing sumoyla-
tion relieves telomeric silencing (Darst et al., 2008; Pasupala
et al., 2012). Themolecular mechanisms underlying these effects
are not fully understood, but are likely to be complex. For
instance, sumoylation is required for the clustering and
anchoring of telomeres to the nuclear periphery, a process that
stabilizes telomeric heterochromatin and limits telomerase
activity (Ferreira et al., 2011; Hari et al., 2001; Zhao and Blobel,
2005).
Finally, sumoylation is involved in telomere maintenance
through effects on the ALT pathway (Figure 3C). In mammalian
cells that utilize ALT, knockdown of the SUMO E3 ligase
Mms21 results in reduced telomere length and increased senes-
cence. Although this may appear to contradict phenotypes
observed in yeast, this effect is unique to ALT and is not
observed if telomerase is introduced into cells (Potts and Yu,
2007). The requirement of sumoylation in ALT is explained in
part because telomere elongation is dependent on assembly of
subnuclear structures formed around telomeres called ALT-
associated PML nuclear bodies (APBs). Similar to PML nuclear
bodies, assembly of APBs is SUMO dependent. Artificially teth-
ering SUMO or Mms21 to telomeric regions is sufficient to
promote APB formation, while Mms21 knockdown limits APB
formation (Chung et al., 2011; Potts and Yu, 2007). Thus, require-
ments for sumoylation in the ALT pathway are due, at least in
part, to an essential role in APB formation.
Centromeres
Centromeres are specialized chromatin structures that form the
foundation for kinetochores, and are therefore essential for
proper chromosome segregation during cell division (Henikoff
and Dalal, 2005). The gene encoding SUMO was first identified
in yeast as a high copy suppressor of a mutant allele of the
centromere-associated protein Mif2 (the vertebrate CENP-C
homolog) (Meluh and Koshland, 1995), providing an early indica-
tion of a connection between sumoylation and centromeres.
Since then, immunofluorescence microscopy has demonstrated
that SUMO-2/3 localizes to centromeres on chromosomes
formed in Xenopus egg extracts and on mammalian mitotic
and meiotic chromosomes (Ayaydin and Dasso, 2004; Azuma
et al., 2005; Brown et al., 2008; La Salle et al., 2008; Vigodner
et al., 2006; Zhang et al., 2008). Furthermore, various SUMO
E3 ligases, including PIASy, PIAS3, and Nup358/RanBP2, are
also present at centromeres ofmitotic chromosomes (Bantignies
et al., 2011; Hari et al., 2001; Joseph et al., 2004; Ryu andAzuma,
2010). Consistent with essential roles in regulating centromere
and kinetochore function in mitosis, chromosome segregation
defects occur when the SUMO pathway is either upregulated
or downregulated (Biggins et al., 2001; Dı´az-Martı´nez et al.,
2006; Hari et al., 2001; Joseph et al., 2004; Mukhopadhyay
et al., 2010; Seufert et al., 1995; Zhang et al., 2008). Segregation,
cohesion, and other roles for sumoylation during mitosis have
been characterized and are reviewed in more detail elsewhere(Dasso, 2008). Here, we focus more specifically on effects of su-
moylation on centromeric heterochromatin.
In contrast to mitosis, few studies have addressed potential
roles for sumoylation at centromeres or kinetochores during
interphase. Of particular interest, it is not known whether
SUMO remains associated with centromeres throughout the
cell cycle or whether its association is specific to mitosis. A
role for sumoylation in the maintenance of centromeric hetero-
chromatin during interphase is, however, suggested by the find-
ings that inhibiting sumoylation in both yeast and mammalian
cells results in activation of genes within normally repressed
centromeric regions (Figure 3D) (Marshall et al., 2010; Shin
et al., 2005; Xhemalce et al., 2007). For example, S. pombe
mutants lacking the Pli1 SUMO E3 ligase exhibit reduced
silencing and enhanced conversion of genes inserted into core
centromeric regions (Xhemalce et al., 2004). How Pli1-depen-
dent sumoylation normally restricts transcription and recombi-
nation within this centromeric region is not fully understood. Inhi-
bition could be mediated through effects on transcription and
recombination factors, or through more direct effects on the
formation and/or maintenance of centromeric heterochromatin.
One mechanism by which centromeric chromatin structure is
regulated by sumoylation is through recruitment of the hetero-
chromatin factor HP1a (Figure 3D). Sumoylation of HP1a regu-
lates its interactionswithmajor a-satellite RNA transcripts, which
in turn directs pericentric DNA targeting (Maison et al., 2011).
Although sumoylation occurs within the hinge domain of HP1a
thought to be involved in RNA binding, the exact molecular
mechanisms underlying SUMO-dependent interactions with
a-satellite RNAs remain to be determined. Intriguingly, further
studies have revealed that depletion of SENP7, a SUMO
protease that localizes to HP1-enriched pericentric domains,
disrupts HP1a localization (Maison et al., 2012). This finding
suggests that localization of HP1a is dependent on transient su-
moylation of HP1a followed by desumoylation and may explain
the common ‘‘SUMO enigma’’ (Hay, 2005) that steady-state
levels of sumoylated HP1a in the cell represent only a relatively
minor fraction of total HP1a. A role for sumoylation in HP1 target-
ing and gene silencing has also been observed in S. pombe,
where HP1 mutants that cannot be sumoylated are less effi-
ciently recruited to heterochromatin domains and compromised
in their ability to repress gene expression (Shin et al.,
2005). Thus, sumoylation of HP1 represents an important and
conserved regulatory point for controlling heterochromatin
structure and gene expression at centromeres and other chro-
matin domains.
Maintenance of Repetitive DNA
Repetitive DNA sequences, including those found at telomeres,
centromeres, andwithin the rDNA gene loci, represent especially
fragile domains in the genome due to issues related to replication
and recombination (Lovett, 2004). The maintenance of these and
other repetitive DNA domains is highly dependent on the activity
of the cohesion-like complex, Smc5/6, and the associated
SUMO E3 ligase, Mms21 (Stephan et al., 2011). Similar to other
SMC complexes, Smc5/6 activities are mediated at least in part
through cohesion-related effects on higher-order chromatin
structure, but also through the targeting of Mms21 to appro-
priate DNA targets. Smc5/6 and Mms21 are essential for theDevelopmental Cell 24, January 14, 2013 ª2013 Elsevier Inc. 7
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chromosomal rearrangements and chromosome segregation
defects. These defects are due in part to the incomplete resolu-
tion of replication-associated homologous recombination inter-
mediates, particularly within the rDNA locus and at telomeres
(Figure 3F) (Behlke-Steinert et al., 2009; Bermu´dez-Lo´pez
et al., 2010; Stephan et al., 2011; Torres-Rosell et al., 2005,
2007).
Although the exact molecular targets and functions of sumoy-
lation in the maintenance of heterochromatic repetitive DNA are
not fully understood, a growing body of evidence indicates that
replication through these domains requires DNA repair factors,
including BRCA1 and Rad51 (Nakamura et al., 2008; Pageau
and Lawrence, 2006). Sumoylation is intimately linked to the
control of these and a large number of other DNA repair factors
(Bergink and Jentsch, 2009; Cremona et al., 2012; Morris et al.,
2009), suggesting that Mms21-dependent sumoylation is
required for proper resolution of DNA repair intermediates
produced during replication. Consistent with this, recombina-
tion-dependent DNA repair intermediates accumulate during
replication in cells deficient in Smc5/6, Ubc9, or Mms21 (Branzei
et al., 2006; Stephan et al., 2011).
Sumoylation also plays an essential role in regulating the
resolution of DNA intermediates at centromeres during sister
chromatid separation in mitosis by affecting the localization
and activities of topoisomerase II (Figure 3F) (Azuma et al.,
2003, 2005; Dawlaty et al., 2008). In addition, immunofluores-
cence microscopy studies in mammalian cells indicate that
centromeres transiently colocalize with PML nuclear bodies in
G2, a phenomena that is enhanced by proteasome inhibition
(Everett et al., 1999). Although the functional significance of
this association remains unexplored, telomere association with
APBs is required for their maintenance in telomerase-deficient
cells. It is therefore tempting to speculate, by analogy to APBs,
that interactions between centromeres and PML nuclear bodies
in late G2 promotes SUMO-dependent reactions required for
maintenance of centromeric DNA.
Future Perspectives and Conclusions
Sumoylation functions as a multifaceted regulator of chromatin
structure, gene expression, and genome integrity. Its utility
resides in part in the ability of SUMO to elicit diverse downstream
consequences following conjugation to different proteins. These
consequences include affects on protein activity, localization,
stability, and interactions with a wide range of SIM-containing
proteins. Understanding the rules that define the effects of
sumoylation on specific chromatin-associated proteins, which
are determined by the nature of the proteins themselves as
well as any downstream interacting proteins, remains an impor-
tant challenge for the field. In particular, understanding how
sumoylation of different proteins mediates interactions with
specific downstream SIM-containing proteins is critical. Speci-
ficity is likely to involve bivalent recognition of SUMO-modified
proteins through downstream factors that contain both SIMs
and motifs for recognizing the modified protein itself, as recently
determined for Srs2 recognition of SUMO-modified PCNA
(Armstrong et al., 2012). Specificity is also very likely to be
determined and regulated by the intersection with other post-
translational modification pathways, including ubiquitylation,8 Developmental Cell 24, January 14, 2013 ª2013 Elsevier Inc.phosphorylation, and acetylation. Understanding the crosstalk
between sumoylation and other posttranslational modifications
in greater detail is also an important challenge for the field.
Defining the role of sumoylation in controlling chromatin
structure and function more specifically and at a molecular level
will also require a more detailed characterization of relevant
SUMO-modified proteins. While the identification of SUMO-
modified proteins with roles in chromatin structure and function
has expanded greatly in the past several years, the functional
effects of sumoylation on the majority of these proteins remain
unknown. Characterizing the effects of sumoylation on individual
proteins is often challenging, due in part to the relatively small
fraction of most proteins modified at steady state. Other chal-
lenges involve identifying approaches for specifically affecting
sumoylation of individual proteins or pathways. While many
important studies linking sumoylation to chromatin structure
and gene expression have relied on global activation or suppres-
sion of sumoylation, more targeted approaches are needed.
The identification of new and functionally unique E3 ligases, as
exemplified by Mms21, represents one avenue for developing
more specific approaches. The identification of separation-
of-function alleles of SUMO or SUMO pathway enzymes in
yeast or other genetically tractable organisms could also prove
valuable.
Finally, a more detailed understanding of the genome-wide
interactions between SUMO (and SUMO pathway enzymes)
and chromatin is needed. ChIP experiments on a small scale
provided the surprising finding the SUMO is associated with
the promoters of active but not repressed genes (Rosonina
et al., 2010). Whole-chromosome ChIP experiments, revealing
genome-wide associations of SUMO during different stages of
the cell cycle or under different cell growth conditions, could
be particularly insightful and provide even more surprises.
In summary, we have reviewed the role of SUMOas a regulator
of chromatin structure and function. In one important capacity,
sumoylation regulates the assembly of multiprotein complexes
on chromatin, including repressive complexes organized around
sites of DNA methylation and PcG bodies, as well as transcrip-
tional regulatory complexes at gene promoters. A recurring
theme from the reviewed studies is the dichotomous role of
sumoylation. By facilitating the assembly of distinct complexes,
sumoylation affects the chromatin environment in ways that can
either activate or repress gene expression. In addition to
facilitating protein complex assembly, sumoylation also affects
proteins in many other ways by mediating changes in localiza-
tion, stability, or enzymatic activity. Thus, another recurring
theme is the diverse and context-dependent effects of sumoyla-
tion on chromatin-associated proteins. Finally, we have re-
viewed the prominent role played by sumoylation in maintaining
the integrity of repetitive heterochromatin domains, including
telomeres, centromeres, and rDNA loci. Collectively, the re-
viewed studies reveal the incredible versatility of sumoylation,
which affects chromatin structure and function at multiple levels
and through multiple mechanisms.ACKNOWLEDGMENTS
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